Review The SDS Document
DOWNLOADProduct Details
Formula
C16H16ClN3O3S
MW
365.83
Purity
>98%
Solubility (DMSO Mg/MI)
70
Storage (Powder)
3 Years -20°C
Storage (Solvent)
1 Year -80°C
Indication
N/A
Mode Of Action
inhibitor
Drug Status
Approved
Target Name
Solute carrier family 12 member 3 (SLC12A3)
Research Area
CARDIOVASCULAR
Research Area Sub Group
Antihypertensive
Pharmacology
TRANSPORTERS
Pharmacology Area Sub Group
Solute Carriers
Bio Chemical Notes
Metolazone(Zaroxolyn) is primarily used to treat congestive heart failure and high blood pressure.